Tryptic peptide screening for primary immunodeficiency disease by LC/MS-MS.

Area of Science:

• Biochemistry
• Immunology
• Proteomics

Background:

• Early diagnosis of primary immunodeficiency disorders (PIDDs) is crucial for patient survival.
• High-throughput screening methods using small blood volumes are needed for PIDD detection.

Purpose of the Study:

• To develop a novel proteomic screening approach for early PIDD diagnosis.
• To identify specific protein markers for severe combined immunodeficiency, Wiskott-Aldrich syndrome, and X-linked Agammaglobulinemia.

Main Methods:

• Developed a tandem mass spectrometry (LC/MS-MS) method.
• Identified signature peptides from CD3ɛ, WASP, and BTK proteins.
• Quantified peptides using labeled standards and normalized to actin.

Main Results:

• Signature peptides from CD3ɛ, WASP, and BTK were detected in cell lysates.
• Absence of these peptides correctly identified PIDD patients.
• The method demonstrated proof of concept for PIDD screening.

Conclusions:

• This proteomic approach is applicable for PIDD screening.
• The method can potentially be multiplexed for additional PIDDs and other disorders.